Accelerating Innovation at Leica Biosystems

Danaher Today D DANAHER ~$28B 2021E TOTAL REVENUE LIFE SCIENCES ~$14.5B cytiva PALL XXIDT Leica SCIEX INTEGRATED DNA KONGLOGES MICROSYSTEMS DIAGNOSTICS ~$9.0B Cepheid. Leica BIOSYSTEMS BECKMAN COULTER RADIOMETERER ENV. & APPLIED ~$4.5B HACH BECKMAN COULTER Life Sciences aldevron TROJAN technologies VIDEOJET. ESKO ChemTreat > x-rite PANTONE® All financial metrics reflect FY 2021E results from continuing operations. Purpose-driven science & technology leader DANAHER

View entire presentation